Teva CEO Erez Vigodman speaks at 2016 SelectUSA Investment Summit

On June 20 at the 2016 SelectUSA Investment Summit in Washington D.C., Erez Vigodman, President & CEO, Teva Pharmaceuticals, spoke to investors, representatives of U.S. economic development organizations, U.S. state and local governments officials and others, about Teva's critical role in delivering value to the U.S. healthcare system and economy.

Mr. Vigodman also spoke about the Teva Impact Report, which is a three-part study highlighting the importance of prescription medicines—both brands and generics—in the U.S.

To access the Teva Impact Report, click here.